CBD Chronic Strain
- This product is available at Attitude Seed Bank, Amsterdam Seed Center, True North Seed Bank.
- At cannabis-seeds-bank.co.uk you can purchase CBD Chronic Strain (Serious Seeds) Pick 'n' Mix for only usd 11.49 , which is 89% less than the cost in True North Seed Bank ($103.13).
- The lowest price of CBD Chronic Strain (Serious Seeds) 6 Seeds was obtained on February 19, 2024 12:09 am.
Description
To create CBD Chronic, Serious Seeds’ biggest yielder Chronic was crossed with Remedy, a strain with extremly high CBD-content, in a collaboration with the CBD-Crew.
The combination was lab-tested in Spain and ALL 10 samples had a 1:1 ratio of THC:CBD. The average potency was 5,4 THC : 5,8 CBD, with the best plant scoring 7,88 THC and 6,93 CBD!
CBD-Chronic can produce top-yields of 600 g/m2 and is easy to grow and clone. She grows a HUGE top-cola with little side-branching.
This first purely medical CBD-strain of Serious Seeds is a milestone, which enables patients/caregivers to produce big amounts of medical cannabis containing high levels of CBD. The production of medical extracts (e.g. Rick Simpson Oil) and lotions, cremes or ointments is made much easier with this strain.
CBD-Chronic is a medical strain, which is very well suited to treat the symptoms of e.g. Multiple Sclerosis, Epilepsy, Tourette syndrome, Glaucoma and Arthritis.
Additional Information
| Seedbank | Serious Seeds |
|---|---|
| Sex | Feminized |
| Pack Size | 6 Seeds |
| Variety | Indica / Sativa |
| Strain Genetics | Chronic x Remedy |
| Flowering Type | Photoperiod |
| Flowering Time | 56-63 days |
| Where to Grow | Indoor, Greenhouse, Outdoor |
| Medical Conditions | Arthritis, Epilepsy, Glaucoma, Multiple Sclerosis, Tourette’s Syndrome |
| CBD Content | 6 – 7 |
| THC Content | 6 – 8 |
| Yield | 350-600 gr/m2 |
decorateTable(‘product-attribute-specs-table’)
CBD Chronic Strain Prices
Price History
Brand
Brand
Serious Seeds
Reviews (0)
User Reviews
Be the first to review “CBD Chronic Strain”
Related Products
There are no reviews yet.